These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23992107)

  • 21. Abnormal functional connectivity of the amygdala is associated with depression in Parkinson's disease.
    Hu X; Song X; Yuan Y; Li E; Liu J; Liu W; Liu Y
    Mov Disord; 2015 Feb; 30(2):238-44. PubMed ID: 25545969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional imaging in Parkinson's disease.
    Dagher A
    Semin Neurol; 2001; 21(1):23-32. PubMed ID: 11346022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroimaging in Parkinson's disease.
    Au WL; Adams JR; Troiano A; Stoessl AJ
    J Neural Transm Suppl; 2006; (70):241-8. PubMed ID: 17017536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.
    Berardelli A; Wenning GK; Antonini A; Berg D; Bloem BR; Bonifati V; Brooks D; Burn DJ; Colosimo C; Fanciulli A; Ferreira J; Gasser T; Grandas F; Kanovsky P; Kostic V; Kulisevsky J; Oertel W; Poewe W; Reese JP; Relja M; Ruzicka E; Schrag A; Seppi K; Taba P; Vidailhet M
    Eur J Neurol; 2013 Jan; 20(1):16-34. PubMed ID: 23279440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New developments of brain imaging for Parkinson's disease and related disorders.
    Piccini P; Brooks DJ
    Mov Disord; 2006 Dec; 21(12):2035-41. PubMed ID: 16874751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroimaging in Parkinson's disease.
    Stoessl AJ
    Neurotherapeutics; 2011 Jan; 8(1):72-81. PubMed ID: 21274687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease.
    Ehrt U; Brønnick K; Leentjens AF; Larsen JP; Aarsland D
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):252-8. PubMed ID: 16477585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Depression in Parkinson's disease].
    Kitamura S; Nagayama H
    Seishin Shinkeigaku Zasshi; 2013; 115(11):1135-41. PubMed ID: 24450146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in neural circuitry associated with depression at pre-clinical, pre-motor and early motor phases of Parkinson's disease.
    Borgonovo J; Allende-Castro C; Laliena A; Guerrero N; Silva H; Concha ML
    Parkinsonism Relat Disord; 2017 Feb; 35():17-24. PubMed ID: 27889469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Imaging non motor signs in Parkinson's disease].
    Thobois S; Ballanger B; Poisson A; Broussolle E
    Rev Neurol (Paris); 2012; 168(8-9):576-84. PubMed ID: 22921250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps.
    Dukart J; Holiga S; Rullmann M; Lanzenberger R; Hawkins PCT; Mehta MA; Hesse S; Barthel H; Sabri O; Jech R; Eickhoff SB
    Hum Brain Mapp; 2021 Feb; 42(3):555-566. PubMed ID: 33079453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced striatal dopamine synthesis capacity is associated with symptoms of depression in patients with de novo unmedicated Parkinson's disease.
    Joutsa J; Rinne JO; Eskola O; Kaasinen V
    J Parkinsons Dis; 2013 Jan; 3(3):325-9. PubMed ID: 23948995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson's Disease: What Do Clinical and Neuroimaging Studies Tell Us?
    Hanganu A; Monchi O
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):91. PubMed ID: 30324260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The use of magnetic resonance imaging (MRI) and single photon emission computing tomography (SPECT) for the differential diagnosis of Parkinson's disease and other neurodegenerative disorders presenting as parkinsonism].
    Kohira I
    Nihon Rinsho; 1997 Jan; 55(1):39-42. PubMed ID: 9014421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging biomarkers in Parkinson's disease.
    Brooks DJ; Pavese N
    Prog Neurobiol; 2011 Dec; 95(4):614-28. PubMed ID: 21896306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in biomarkers for Parkinson's disease focusing on biochemicals, omics and neuroimaging.
    Ren R; Sun Y; Zhao X; Pu X
    Clin Chem Lab Med; 2015 Sep; 53(10):1495-506. PubMed ID: 25581757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intact limbic-prefrontal connections and reduced amygdala volumes in Parkinson's disease with mild depressive symptoms.
    Surdhar I; Gee M; Bouchard T; Coupland N; Malykhin N; Camicioli R
    Parkinsonism Relat Disord; 2012 Aug; 18(7):809-13. PubMed ID: 22652466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.